113 related articles for article (PubMed ID: 38451055)
21. Development and in vitro evaluation of chitosan based system for local delivery of atorvastatin for treatment of periodontitis.
Işılay Özdoğan A; Akca G; Şenel S
Eur J Pharm Sci; 2018 Nov; 124():208-216. PubMed ID: 30171985
[TBL] [Abstract][Full Text] [Related]
22. Chitosan-coated nanostructured lipid carriers for transdermal delivery of tetrahydrocurcumin for breast cancer therapy.
Truong TH; Alcantara KP; Bulatao BPI; Sorasitthiyanukarn FN; Muangnoi C; Nalinratana N; Vajragupta O; Rojsitthisak P; Rojsitthisak P
Carbohydr Polym; 2022 Jul; 288():119401. PubMed ID: 35450653
[TBL] [Abstract][Full Text] [Related]
23. Antibody-decorated chitosan-iodoacetamide-coated nanocarriers for the potential delivery of doxorubicin to breast cancer cells.
Myat YY; Sahatsapan N; Rojanarata T; Ngawhirunpat T; Opanasopit P; Pornpitchanarong C; Patrojanasophon P
Int J Biol Macromol; 2024 Feb; 258(Pt 1):128797. PubMed ID: 38104687
[TBL] [Abstract][Full Text] [Related]
24. Human Growth Hormone Fragment 176-191 Peptide Enhances the Toxicity of Doxorubicin-Loaded Chitosan Nanoparticles Against MCF-7 Breast Cancer Cells.
Habibullah MM; Mohan S; Syed NK; Makeen HA; Jamal QMS; Alothaid H; Bantun F; Alhazmi A; Hakamy A; Kaabi YA; Samlan G; Lohani M; Thangavel N; Al-Kasim MA
Drug Des Devel Ther; 2022; 16():1963-1974. PubMed ID: 35783198
[TBL] [Abstract][Full Text] [Related]
25. pH-Responsive Selenium Nanoplatform for Highly Efficient Cancer Starvation Therapy by Atorvastatin Delivery.
Xiao J; Sun Q; Ran L; Wang Y; Qin X; Xu X; Tang C; Liu L; Zhang G
ACS Biomater Sci Eng; 2023 Feb; 9(2):809-820. PubMed ID: 36622161
[TBL] [Abstract][Full Text] [Related]
26. Mitotropic triphenylphosphonium doxorubicin-loaded core-shell nanoparticles for cellular and mitochondrial sequential targeting of breast cancer.
Arafa KK; Smyth HDC; El-Sherbiny IM
Int J Pharm; 2021 Sep; 606():120936. PubMed ID: 34310958
[TBL] [Abstract][Full Text] [Related]
27. Lung-targeting drug delivery system of baicalin-loaded nanoliposomes: development, biodistribution in rabbits, and pharmacodynamics in nude mice bearing orthotopic human lung cancer.
Wei Y; Liang J; Zheng X; Pi C; Liu H; Yang H; Zou Y; Ye Y; Zhao L
Int J Nanomedicine; 2017; 12():251-261. PubMed ID: 28096670
[TBL] [Abstract][Full Text] [Related]
28. Enhanced oral absorption of 20(S)-protopanaxadiol by self-assembled liquid crystalline nanoparticles containing piperine: in vitro and in vivo studies.
Jin X; Zhang ZH; Sun E; Tan XB; Li SL; Cheng XD; You M; Jia XB
Int J Nanomedicine; 2013; 8():641-52. PubMed ID: 23426652
[TBL] [Abstract][Full Text] [Related]
29. Development and evaluation of magnetic microemulsion: tool for targeted delivery of camptothecin to BALB/c mice-bearing breast cancer.
Natesan S; Sugumaran A; Ponnusamy C; Jeevanesan V; Girija G; Palanichamy R
J Drug Target; 2014 Dec; 22(10):913-26. PubMed ID: 25119147
[TBL] [Abstract][Full Text] [Related]
30. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K
J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978
[TBL] [Abstract][Full Text] [Related]
31. Lipidic cubic-phase leflunomide nanoparticles (cubosomes) as a potential tool for breast cancer management.
Zewail M; E Gaafar PM; Ali MM; Abbas H
Drug Deliv; 2022 Dec; 29(1):1663-1674. PubMed ID: 35616281
[TBL] [Abstract][Full Text] [Related]
32. Perivascular sustained release of atorvastatin from a hydrogel-microparticle delivery system decreases intimal hyperplasia.
Mylonaki I; Strano F; Deglise S; Allémann E; Alonso F; Corpataux JM; Dubuis C; Haefliger JA; Jordan O; Saucy F; Delie F
J Control Release; 2016 Jun; 232():93-102. PubMed ID: 27091698
[TBL] [Abstract][Full Text] [Related]
33. Radioiodination, nasal nanoformulation and preliminary evaluation of isovanillin: A new potential brain cancer-targeting agent.
El-Kawy OA; Shweeta HA; Attallah KM
Appl Radiat Isot; 2022 Nov; 189():110464. PubMed ID: 36150311
[TBL] [Abstract][Full Text] [Related]
34. RGD functionalized chitosan nanoparticle mediated targeted delivery of raloxifene selectively suppresses angiogenesis and tumor growth in breast cancer.
Yadav AS; Radharani NNV; Gorain M; Bulbule A; Shetti D; Roy G; Baby T; Kundu GC
Nanoscale; 2020 May; 12(19):10664-10684. PubMed ID: 32374338
[TBL] [Abstract][Full Text] [Related]
35. In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle.
Rezazadeh M; Emami J; Hasanzadeh F; Sadeghi H; Minaiyan M; Mostafavi A; Rostami M; Lavasanifar A
Drug Deliv; 2016 Jun; 23(5):1707-17. PubMed ID: 25188785
[TBL] [Abstract][Full Text] [Related]
36. Bufalin loaded biotinylated chitosan nanoparticles: an efficient drug delivery system for targeted chemotherapy against breast carcinoma.
Tian X; Yin H; Zhang S; Luo Y; Xu K; Ma P; Sui C; Meng F; Liu Y; Jiang Y; Fang J
Eur J Pharm Biopharm; 2014 Aug; 87(3):445-53. PubMed ID: 24846793
[TBL] [Abstract][Full Text] [Related]
37. Injectable hydrogels for the sustained delivery of a HER2-targeted antibody for preventing local relapse of HER2+ breast cancer after breast-conserving surgery.
Chen X; Wang M; Yang X; Wang Y; Yu L; Sun J; Ding J
Theranostics; 2019; 9(21):6080-6098. PubMed ID: 31534538
[TBL] [Abstract][Full Text] [Related]
38. Indocyanine green/doxorubicin-encapsulated functionalized nanoparticles for effective combination therapy against human MDR breast cancer.
Chen HH; Lu IL; Liu TI; Tsai YC; Chiang WH; Lin SC; Chiu HC
Colloids Surf B Biointerfaces; 2019 May; 177():294-305. PubMed ID: 30771581
[TBL] [Abstract][Full Text] [Related]
39. Brain-targeting study of stearic acid-grafted chitosan micelle drug-delivery system.
Xie YT; Du YZ; Yuan H; Hu FQ
Int J Nanomedicine; 2012; 7():3235-44. PubMed ID: 22802685
[TBL] [Abstract][Full Text] [Related]
40. Development of novel biotinylated chitosan-decorated docetaxel-loaded nanocochleates for breast cancer targeting.
Poudel I; Ahiwale R; Pawar A; Mahadik K; Bothiraja C
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):229-240. PubMed ID: 29575931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
